Cancer of Lung: Clinical Trials

1 trial for Cancer of Lung, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Active not recruiting 1
Phase 21Active not recruiting 1

Follow Cancer of Lung: new trials by email Literature Review of Cancer of Lung trials Research Report on Cancer of Lung

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
JDQ443, TNO155, tislelizumab - KRAS G12C Mutant Solid Tumors, Carcinoma, Non-Small-Cell Lung
Phase 1 / Phase 2Active not recruitingNovartis Pharmaceuticals3442021-02-242026-10-19

Narrower conditions

Carcinoma, Non-Small-Cell Lung (1)  ·  Colorectal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Bronchial Neoplasms (1)  ·  Carcinoma, Bronchogenic (1)  ·  Colonic Diseases (1)  ·  Digestive System Diseases (1)  ·  Digestive System Neoplasms (1)  ·  Gastrointestinal Diseases (1)  ·  Gastrointestinal Neoplasms (1)  ·  Intestinal Diseases (1)  ·  Intestinal Neoplasms (1)  ·  Lung Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

JDQ443 (1)  ·  tislelizumab (1)

Sponsors

Novartis Pharmaceuticals (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  France (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Italy (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Spain (1)  ·  Taiwan (1)

Results publications

PMID 36399068